Back to Journals » Breast Cancer: Targets and Therapy » Volume 4

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

Total article views   HTML views PDF downloads Totals
14,276 Dovepress* 12,563+ 3,135 15,698
PubMed Central* 1,713 1,445 3,158
Totals 14,276 4,580 18,856
*Since 27 August 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar